MedPath

Efficacy of Kushthadi Churna in Madhumeha.

Not yet recruiting
Conditions
Ayurveda health condition Madhumeha(Diabetes Mellitus)
Type 2 diabetes mellitus without complications,
Registration Number
CTRI/2021/06/034041
Lead Sponsor
Pratima Prafulla Mohite
Brief Summary

I am Pratima Prafulla Mohite PG Scholar Kaya-Chikitsa trying to evaluate the efficacy of Kushthadi Churna in Madhumeha.

During this trial trying to evaluate the untoward effect of Kushthadi Churna in Madhumeha as there is no previous work done on Kushthadi Churna.

SO emphasis will be made to find out easy,cost effective method to control Hyperglyacemia with no side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients aged between 25-70 years with irrespective of gender, education, religion, socio-economic class.
  • Patients presenting with classical features of Madhumeha, that is- i.
  • Pipasavridhhi (polydipsia) ii.
  • Prabhut- mutrata(polyuria) iii.
  • Avila – mutrata (turbidity) iv.
  • Naktamutrata 3.
  • Patients with history of Madhumeha.
Exclusion Criteria
  • Patients with Insulin Dependent Diabetes Mellitus.
  • Patients aged less than 25 years and more than 70 years.
  • Patient presenting with Madhumeha due to the complication of other major systemic disease.
  • Pregnant women and lactating mothers will be excluded.
  • Any acute emergency conditions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Determine the efficacy of Kushthadi Churna In Madhumeha.4 weeks
Secondary Outcome Measures
NameTimeMethod
To review Literature of Madhumeha.4 weeks

Trial Locations

Locations (1)

Hon Shri Annasaheb Dange Ayurveda medical college

🇮🇳

Sangli, MAHARASHTRA, India

Hon Shri Annasaheb Dange Ayurveda medical college
🇮🇳Sangli, MAHARASHTRA, India
Pratima Prafulla Mohite
Principal investigator
8806865823
mohitepratima8@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.